Kelly Morales
Obstetrics & Gynecology · San Antonio, TXNPI 1407816135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 39 manufacturers reported payments, led by AbbVie at 34.9% of the total.
Across 255 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Mayne Pharma Commercial LLC$417
- Astellas Pharma US Inc$274
- Shield Therapeutics Inc$242
- Evofem Biosciences, Inc.$233
- Daiichi Sankyo Inc.$192
- plus $2K from 33 others
What the payments were for
- Consulting fees$170%
- Food & beverage$4,81097%
- Education$1563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 101 | $1,740 |
| Mayne Pharma Commercial LLC | 16 | $417 |
| Astellas Pharma US Inc | 9 | $274 |
| Shield Therapeutics Inc | 17 | $242 |
| Evofem Biosciences, Inc. | 17 | $233 |
| Daiichi Sankyo Inc. | 11 | $192 |
| Hologic Sales And Service, LLC | 7 | $191 |
| Sumitomo Pharma America, Inc. | 5 | $186 |
| Medtronic | 1 | $151 |
| Biogen | 4 | $149 |
| Pacira Pharmaceuticals Incorporated | 2 | $147 |
| Merck | 7 | $117 |
| Organon | 7 | $89 |
| Coopersurgical, Inc. | 4 | $75 |
| Therapeuticsmd, Inc. | 5 | $70 |
| Aspira Women's Health Inc | 4 | $68 |
| Exeltis, USA Inc. | 3 | $56 |
| Pharming Healthcare, Inc. | 2 | $53 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Meditrina | 2 | $38 |
| Duchesnay USA Incorporated | 3 | $37 |
| Myovant Sciences Inc. | 2 | $35 |
| Davol Inc. | 2 | $33 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| Avanos Medical | 1 | $31 |
| Mylan Pharmaceuticals Inc. | 2 | $29 |
| Avion Pharmaceuticals | 2 | $26 |
| Cumberland Pharmaceuticals, Inc. | 2 | $24 |
| Axonics, Inc. | 1 | $23 |
| BD | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Sanara Medtech Inc. | 2 | $19 |
| Medicem Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Lupin Inc. | 1 | $16 |
| Millicent US Inc | 1 | $15 |
| Acessa Health Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,983 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 67 | $4,194 |
| ProgesteroneProgesterone, Micronized | 46 | $1,953 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Antonio
- Henry Garza IiiSan Antonio$258K
- Valentin AlmendarezSan Antonio$215K
- Camilo GonimaSan Antonio$203K
- Paulina RamirezSan Antonio$51K
- Paula BilicaSan Antonio$41K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.